SCHEMBL6849062

SCHEMBL6849062

O=S(=O)(O)c1ccccc1N1CCNC(c2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 1/20 0.47
HTR6 P50406 1/20 0.44
GSK3B P49841 4/20 0.41
PRKCQ Q04759 4/20 0.41
PDE10A Q9Y233 1/20 0.39
MYC P01106 1/20 0.39
PRKCD Q05655 1/20 0.37
NAPEPLD Q6IQ20 1/20 0.37
BTK Q06187 1/20 0.36
NOTUM Q6P988 2/20 0.35
SMYD3 Q9H7B4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2849210 0.82 MYC (0.45) HTR6PRKCQMYCPRKCD
SCHEMBL6849293 0.81 HTR6 (0.43) RPS6KB1HTR6MYCNOTUM
SCHEMBL6288232 0.81 HTR6 (0.43) RPS6KB1HTR6MYCNOTUM
Water SCHEMBL5996484 0.81 MYC (0.44) HTR6PRKCQMYCPRKCD
SCHEMBL6847420 0.78 HDAC1 (0.41) HTR6PRKCQMYCPRKCD
SCHEMBL6848056 0.78 LATS1 (0.40) HTR6PRKCQMYCNOTUM
SCHEMBL6847591 0.76 HTR6 (0.39) HTR6MYCNOTUM
SCHEMBL2851145 0.76 ADRB1 (0.41) HTR6MYC
SCHEMBL8632814 0.75 HTR6 (0.67) HTR6MYC
Water SCHEMBL6904877 0.74 HTR6 (0.65) HTR6MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100486574-C Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2009-05-13 CN claimed
CN-1946396-A Medicine for prevention and/or treatment of ischemic circulatory disease MITSUBISHI PHARMA CORP (JP) 2007-04-11 CN claimed
CN-1638773-A Pharmaceutical preparation containing aminobenzenesulfonic acid derivative as active ingredient MITSUBISHI PHARMA CORP (JP) 2005-07-13 CN claimed
CN-1533292-A Medicament inhititing sodium/calcium exchange system 三菱制药株式会社 2004-09-29 CN claimed
CN-1496261-A Remedies and/or preventives for diabetic ischemic heart diseases 三菱制药株式会社 2004-05-12 CN claimed
EP-1374868-A1 REMEDIES AND/OR PREVENTIVES FOR DIABETIC ISCHEMIC HEART DISEASES Mitsubishi Pharma Corporation (JP) 2004-01-02 EP claimed
CN-1434724-A Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2003-08-06 CN claimed
CN-100502861-C Medicament inhibiting sodium/calcium exchange system MITSUBISHI PHARMA CORP (JP) 2009-06-24 CN disclosed
CN-100496495-C Remedies and/or preventives for diabetic ischemic heart diseases MITSUBISHI PHARMA CORP (JP) 2009-06-10 CN disclosed
CN-100486574-C Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2009-05-13 CN disclosed
CN-1946396-A Medicine for prevention and/or treatment of ischemic circulatory disease MITSUBISHI PHARMA CORP (JP) 2007-04-11 CN disclosed
CN-1638773-A Pharmaceutical preparation containing aminobenzenesulfonic acid derivative as active ingredient MITSUBISHI PHARMA CORP (JP) 2005-07-13 CN disclosed
CN-1533292-A Medicament inhititing sodium/calcium exchange system 三菱制药株式会社 2004-09-29 CN disclosed
CN-1496261-A Remedies and/or preventives for diabetic ischemic heart diseases 三菱制药株式会社 2004-05-12 CN disclosed
EP-1374868-A1 REMEDIES AND/OR PREVENTIVES FOR DIABETIC ISCHEMIC HEART DISEASES Mitsubishi Pharma Corporation (JP) 2004-01-02 EP disclosed
CN-1434724-A Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2003-08-06 CN disclosed